This conference has been CANCELLED.

Critical Care and Pulmonology: Clinical and Pharmacological Principles and Practices is organized by Continuing Education, Inc. and will be held from May 18 - 28, 2020 at Celebrity Reflection, Dublin, Leinster, Ireland.

Target Audience:
Pharmacists, Physicians, Nurses, Nurse Practitioners, Physician Assistants

Credits:
• 16 AMA PRA Category 1 Credits™
• 16 ACPE Credits
• 16 (part II) MOC points in medical knowledge in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
• 16.0 Contact Hours

Program Purpose:?
The purpose of these lectures is to update clinicians/prescribers on pharmacological principles and practices that can be applied during Critical Care and Pulmonology interventions.

The desired outcome is that attendees will adopt the stated learning objectives to improve their professional practice.
• Review of the 2019 Beers list and highlights of changes made since 2015
• Drug interactions; a primer and refresher for all areas of clinical practice
• Navigating FDA black box warnings
• Addressing mental health comorbidity in patients with medical illness

Topics:
• Update clinicians on pharmacological principles and practices: Review of the 2019 Beers list and highlights of changes made since 2015
? List potentially inappropriate medications (PIMS) that have been identified by the 2019 Beers criteria
? Identify the challenges of applying the changes recommended on the 2019 updated Beers list
? Apply clinical pearls to improve medication medication safety in this population

• Update clinicians on pharmacological principles and practices: Drug interactions; a primer and refresher for all areas of clinical practice
? Describe key principles involved in identifying and mitigating potential adverse outcomes associated with drug interactions
? Identify the challenges of conducting risk assessments and developing a strategy to address these issues
? Apply clinical pearls to improve medication medication safety when navigating drug interactions

• Update clinicians on pharmacological principles and practices: Navigating FDA black box warnings
? Describe key principles involved in identifying and mitigating potential adverse outcomes associated with black box warnings
? Identify the challenges of conducting risk assessments and developing a strategy to address these issues
? Apply clinical pearls to improve medication medication safety when navigating FDA black box warnings

• Update clinicians on pharmacological principles and practices: Addressing mental health comorbidity in patients with medical illness
? Describe the challenges associated with managing patients with psychiatric and medical comorbid illness
? Identify the key pharmacologic principles involved in concomitant medication therapy
? Apply clinical pearls to improve medication medication safety in this population